PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31308291-3	2019	The aim of this study was to determine if YM155, a small-molecule survivin inhibitor, potentiates the chemotherapeutic efficacy of etoposide against canine OSA in vitro and in vivo.	YM 155	42-47	baculoviral IAP repeat containing 5	Canis lupus familiaris	66-74	
33160684-0	2021	Commitment toward cell death by activation of autophagy with survivin inhibitor YM155 in two canine squamous cell carcinoma cell lines with high expression of survivin.	YM 155	80-85	baculoviral IAP repeat containing 5	Canis lupus familiaris	61-69	
33160684-0	2021	Commitment toward cell death by activation of autophagy with survivin inhibitor YM155 in two canine squamous cell carcinoma cell lines with high expression of survivin.	YM 155	80-85	baculoviral IAP repeat containing 5	Canis lupus familiaris	159-167	
33160684-2	2021	Recently, survivin inhibitor YM155 was shown to have growth inhibitory activity on high-survivin-expressing canine SCC cell lines HAPPY and SQ4.	YM 155	29-34	baculoviral IAP repeat containing 5	Canis lupus familiaris	10-18	
33160684-2	2021	Recently, survivin inhibitor YM155 was shown to have growth inhibitory activity on high-survivin-expressing canine SCC cell lines HAPPY and SQ4.	YM 155	29-34	baculoviral IAP repeat containing 5	Canis lupus familiaris	88-96	
25744435-4	2015	Sepantronium bromide (YM155) has recently been established as a novel survivin-targeting agent.	YM 155	0-20	baculoviral IAP repeat containing 5	Canis lupus familiaris	70-78	
30268330-0	2018	Canine squamous cell carcinoma cell lines with high expression of survivin are sensitive to survivin inhibitor YM155.	YM 155	111-116	baculoviral IAP repeat containing 5	Canis lupus familiaris	66-74	
30268330-0	2018	Canine squamous cell carcinoma cell lines with high expression of survivin are sensitive to survivin inhibitor YM155.	YM 155	111-116	baculoviral IAP repeat containing 5	Canis lupus familiaris	92-100	
30268330-2	2018	Survivin is a member of the inhibitor of apoptosis protein family and its inhibitor, YM155, is a potential anti-tumour agent.	YM 155	85-90	baculoviral IAP repeat containing 5	Canis lupus familiaris	0-8	
26048444-3	2015	Sepantronium bromide (YM155) is a potential novel survivin-targeting agent and in this study the influence of survivin expression on clinical outcomes and the effects of YM155 on biological activities in HS cells were investigated.	YM 155	0-20	baculoviral IAP repeat containing 5	Canis lupus familiaris	50-58	
25744435-4	2015	Sepantronium bromide (YM155) has recently been established as a novel survivin-targeting agent.	YM 155	22-27	baculoviral IAP repeat containing 5	Canis lupus familiaris	70-78	
18348340-1	2008	This paper describes a sensitive and selective liquid chromatography with tandem mass spectrometry (LC-MS/MS) method for determination of the novel survivin suppressant YM155, 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazolium, which is developed for the treatment of solid tumors.	YM 155	169-174	baculoviral IAP repeat containing 5	Canis lupus familiaris	148-156